Feature

340B Rebate Clash Triggers 5 Suits By Drugmakers

By Dan McKay · February 18, 2025, 6:07 PM EST

The federal agency overseeing the 340B drug pricing program faces five distinct legal challenges by drugmakers that say the agency illegally blocked their plans to offer rebates rather than upfront discounts...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. v. BECERRA et al

Case Number

1:24-cv-03188

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

November 12, 2024

Case Title

ELI LILLY AND COMPANY et al v. XAVIER BECERRA et al

Case Number

1:24-cv-03220

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

November 14, 2024

Case Title

BRISTOL MYERS SQUIBB COMPANY v. JOHNSON et al

Case Number

1:24-cv-03337

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Date Filed

November 26, 2024

Case Title

SANOFI-AVENTIS U.S. LLC v. UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES et al

Case Number

1:24-cv-03496

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Date Filed

December 16, 2024

Case Title

NOVARTIS PHARMACEUTICALS CORPORATION v. BECERRA et al

Case Number

1:25-cv-00117

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

January 15, 2025

Recent Articles By Dan